Related Experiment Videos
[Long-term prognosis after interferon therapy in chronic hepatitis type C]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 1, 1994
Summary
Interferon therapy for chronic hepatitis C showed varied responses, with 36% achieving complete response. Long-term follow-up revealed cirrhosis development in some patients, highlighting the need for ongoing monitoring.
Area of Science:
- Hepatology
- Virology
- Immunology
Context:
- Chronic hepatitis C (HCV) infection poses a significant global health burden.
- Interferon-based therapies have been a cornerstone treatment for HCV.
- Assessing long-term outcomes and predictors of response is crucial for patient management.
Purpose:
- To evaluate the long-term efficacy and safety of interferon therapy in chronic hepatitis C patients.
- To analyze treatment response rates (complete, partial, no response).
- To investigate the development of liver cirrhosis post-therapy and its correlation with baseline histopathology and viral load.
Summary:
- A cohort of 263 chronic hepatitis C patients receiving interferon therapy was followed for an average of 2.7 years.
- Treatment outcomes included 36% complete response, 16% partial response, and 48% no response.
- Among 96 patients with post-therapy liver biopsies, 13 progressed to liver cirrhosis, with pre-treatment histopathology and HCV-DNA probes examined.
Impact:
- Provides insights into the real-world effectiveness of interferon therapy for chronic hepatitis C.
- Identifies potential risk factors for cirrhosis development after treatment.
- Informs clinical decision-making regarding interferon therapy and post-treatment surveillance strategies.